Identification of a 3 kb Alu-mediated BRCA1 gene rearrangement in two breast ovarian cancer families

被引:68
作者
Montagna, M
Santacatterina, M
Torri, A
Menin, C
Zullato, D
Chieco-Bianchi, L
D'Andrea, E
机构
[1] Univ Padua, Interuniv Ctr Res Canc, Dept Oncol & Surg Sci, Oncol Sect, I-35128 Padua, Italy
[2] Univ Padua, Interuniv Ctr Res Canc, IST Biotechnol Sect, I-35128 Padua, Italy
关键词
BRCA1; genomic rearrangement; breast cancer; ovarian cancer; Alu repeats;
D O I
10.1038/sj.onc.1202754
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Most of the hereditary breast cancers are attributed to constitutive alterations of either BRCA1 or BRCA2 genes; nonetheless, germline mutations of these genes in 'high risk' families are found less frequently than expected from linkage data. Recent findings suggest that major genomic rearrangements of the BRCA1 gene might account for at least some of the apparently mutation negative cases. We studied 60 affected probands belonging to families with a strong history of breast and/or ovarian cancer who scored negative for BRCA1 gene mutations by PTT and SSCP analysis, DNA was analysed by the Southern blotting procedure using three different restriction enzymes, and tno probes obtained by RT-PCR of the 5' and 3' BRCA1 coding sequence. A 3 kb deletion encompassing exon 17 and causing a frameshift mutation was identified in two independently ascertained families. RT-PCR and long-range DNA PCR were employed to characterize the rearrangement that was finally shown to be the result of a recombination between tno very similar Alu repeats. This type of mutation is not identified by the conventional methods of mutation detection which are based on PCR amplification of single exons, Therefore, further search for gene rearrangements is needed to better define the proportion of 'high risk' families that might be explained by gross genomic alterations of the BRCA1 gene.
引用
收藏
页码:4160 / 4165
页数:6
相关论文
共 17 条
[1]  
CLAUS EB, 1991, AM J HUM GENET, V48, P232
[2]   Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families [J].
Ford, D ;
Easton, DF ;
Stratton, M ;
Narod, S ;
Goldgar, D ;
Devilee, P ;
Bishop, DT ;
Weber, B ;
Lenoir, G ;
Chang-Claude, J ;
Sobol, H ;
Teare, MD ;
Struewing, J ;
Arason, A ;
Scherneck, S ;
Peto, J ;
Rebbeck, TR ;
Tonin, P ;
Neuhausen, S ;
Barkardottir, R ;
Eyfjord, J ;
Lynch, H ;
Ponder, BAJ ;
Gayther, SA ;
Birch, JM ;
Lindblom, A ;
Stoppa-Lyonnet, D ;
Bignon, Y ;
Borg, A ;
Hamann, U ;
Haites, N ;
Scott, RJ ;
Maugard, CM ;
Vasen, H .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (03) :676-689
[3]   CONFIRMATION OF BRCA1 LAY ANALYSIS OF GERMLINE MUTATIONS LINKED TO BREAST AND OVARIAN-CANCER IN 10 FAMILIES [J].
FRIEDMAN, LS ;
OSTERMEYER, EA ;
SZABO, CI ;
DOWD, P ;
LYNCH, ED ;
ROWELL, SE ;
KING, MC .
NATURE GENETICS, 1994, 8 (04) :399-404
[4]   GERMLINE MUTATIONS OF THE BRCA1 GENE IN BREAST AND OVARIAN-CANCER FAMILIES PROVIDE EVIDENCE FOR A GENOTYPE-PHENOTYPE CORRELATION [J].
GAYTHER, SA ;
WARREN, W ;
MAZOYER, S ;
RUSSELL, PA ;
HARRINGTON, PA ;
CHIANO, M ;
SEAL, S ;
HAMOUDI, R ;
VANRENSBURG, EJ ;
DUNNING, AM ;
LOVE, R ;
EVANS, G ;
EASTON, D ;
CLAYTON, D ;
STRATTON, MR ;
PONDER, BAJ .
NATURE GENETICS, 1995, 11 (04) :428-433
[5]   RAPID DETECTION OF BRCA1 MUTATIONS BY THE PROTEIN TRUNCATION TEST [J].
HOGERVORST, FBL ;
CORNELIS, RS ;
BOUT, M ;
VANVLIET, M ;
OOSTERWIJK, JC ;
OLMER, R ;
BAKKER, B ;
KLIJN, JGM ;
VASEN, HFA ;
MEIJERSHEIJBOER, H ;
MENKO, FH ;
CORNELISSE, CJ ;
DENDUNNEN, JT ;
DEVILEE, P ;
VANOMMEN, GJB .
NATURE GENETICS, 1995, 10 (02) :208-212
[6]   Interrelationships of the pathways of mRNA decay and translation in eukaryotic cells [J].
Jacobson, A ;
Peltz, SW .
ANNUAL REVIEW OF BIOCHEMISTRY, 1996, 65 :693-739
[7]   A STRONG CANDIDATE FOR THE BREAST AND OVARIAN-CANCER SUSCEPTIBILITY GENE BRCA1 [J].
MIKI, Y ;
SWENSEN, J ;
SHATTUCKEIDENS, D ;
FUTREAL, PA ;
HARSHMAN, K ;
TAVTIGIAN, S ;
LIU, QY ;
COCHRAN, C ;
BENNETT, LM ;
DING, W ;
BELL, R ;
ROSENTHAL, J ;
HUSSEY, C ;
TRAN, T ;
MCCLURE, M ;
FRYE, C ;
HATTIER, T ;
PHELPS, R ;
HAUGENSTRANO, A ;
KATCHER, H ;
YAKUMO, K ;
GHOLAMI, Z ;
SHAFFER, D ;
STONE, S ;
BAYER, S ;
WRAY, C ;
BOGDEN, R ;
DAYANANTH, P ;
WARD, J ;
TONIN, P ;
NAROD, S ;
BRISTOW, PK ;
NORRIS, FH ;
HELVERING, L ;
MORRISON, P ;
ROSTECK, P ;
LAI, M ;
BARRETT, JC ;
LEWIS, C ;
NEUHAUSEN, S ;
CANNONALBRIGHT, L ;
GOLDGAR, D ;
WISEMAN, R ;
KAMB, A ;
SKOLNICK, MH .
SCIENCE, 1994, 266 (5182) :66-71
[8]  
Montagna M, 1996, CANCER RES, V56, P5466
[9]  
Neuhausen SL, 1996, AM J HUM GENET, V58, P271
[10]   BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients [J].
PetrijBosch, A ;
Peelen, T ;
vanVliet, M ;
vanEijk, R ;
Olmer, R ;
Drusedau, M ;
Hogervorst, FBL ;
Hageman, S ;
Arts, PJW ;
Ligtenberg, MJL ;
MeijersHeijboer, H ;
Klijn, JGM ;
Vasen, HFA ;
Cornelisse, CJ ;
vantVeer, LJ ;
Bakker, E ;
vanOmmen, GJB ;
Devilee, P .
NATURE GENETICS, 1997, 17 (03) :341-345